HeartSciences Inc. (HSCS)

Market Cap	4.37M
Revenue (ttm)	n/a
Net Income (ttm)	-8.52M
Shares Out	1.08M
EPS (ttm)	-10.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	135,882
Open	3.820
Previous Close	3.790
Day's Range	3.734 - 4.190
52-Week Range	2.360 - 5.299
Beta	2.59
Analysts	Strong Buy
Price Target	13.00 (+221.78%)
Earnings Date	Jul 28, 2025

About HSCS

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility. It is developing artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 15, 2022
• Employees: 15
• Stock Exchange: NASDAQ
• Ticker Symbol: HSCS
• Website: https://heartsciences.com

Financial Performance

In 2024, HeartSciences's revenue was $18,600, an increase of 261.17% compared to the previous year's $5,150. Losses were -$6.61 million, 3.95% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for HSCS stock is "Strong Buy." The 12-month stock price target is $13.0, which is an increase of 221.78% from the latest price.

Price Target

$13.0

(221.78% upside)

Analyst Consensus: Strong Buy